1. Benca RM. Consequences of insomnia and its therapies. J Clin Psychiatry 2001;62 Suppl 10:33-8.
2. Meissner HH, Riemer A, Santiago SM, Stein M, Goldman MD, Williams AJ. Failure of physician documentation of sleep complaints in hospitalized patients. West J Med 1998;169(3):146-9.
3. Katz D, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract 2002;51(3):229-35.
4. Iliescu EA, Coo H, McMurray MH, et al. Quality of sleep and health-related quality of life in haemodialysis patients. Nephrol Dial Transplant 2003;18(1):126-32.
5. Sanner BM, Tepel M, Esser M, et al. Sleep-related breathing disorders impair quality of life in haemodialysis recipients. Nephrol Dial Transplant 2002;17(7):1260-5.
6. Benz RL, Pressman MR, Hovick ET, Peterson DD. A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study).
Am J Kidney Dis 1999;34(6):1089-95.
7. Wetter TC, Stiasny K, Kohnen R, Oertel WH, Trenkwalder C. Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome. Mov Disord 1998;13(5):820-4.
8. Stepanski E, Faber M, Zorick F, Basner R, Roth T. Sleep disorders in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995;6(2):192-7.
9. Millman RP, Kimmel PL, Shore ET, Wasserstein AG. Sleep apnea in hemodialysis patients: the lack of testosterone effect on its pathogenesis. Nephron
1985;40(4):407-10.
10. Kuhlmann U, Becker HF, Birkhahn M, et al. Sleep-apnea in patients with end-stage renal disease and objective results. Clin Nephrol 2000;53(6):460-6.
11. Hanly PJ, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001;344(2):102-7.
12. Hanly PJ, Gabor JY, Chan C, Pierratos A. Daytime sleepiness in patients with CRF:
impact of nocturnal hemodialysis. Am J Kidney Dis 2003;41(2):403-10.
13. Pressman MR, Benz RL, Schleifer CR, Peterson DD. Sleep disordered breathing in ESRD: acute beneficial effects of treatment with nasal continuous positive airway pressure. Kidney Int 1993;43(5):1134-9.
14. Parker KP, Bliwise DL, Bailey JL, Rye DB. Daytime sleepiness in stable hemodialysis patients. Am J Kidney Dis 2003;41(2):394-402.
15. Holley JL, Nespor S, Rault R. A comparison of reported sleep disorders in patients on chronic hemodialysis and continuous peritoneal dialysis. Am J Kidney Dis
1992;19(2):156-61.
16. Sabbatini M, Minale B, Crispo A, et al. Insomnia in maintenance haemodialysis patients. Nephrol Dial Transplant 2002;17(5):852-6.
17. Kraus MA, Hamburger RJ. Sleep apnea in renal failure. Adv Perit Dial 1997;13:88-92.
18. Benz RL, Pressman MR, Hovick ET, Peterson DD. Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders. Am J Kidney Dis 2000;35(6):1052-60.
19. Fletcher EC. Obstructive sleep apnea and the kidney. J Am Soc Nephrol 1993;4(5):1111-21.
20. Kimmel PL, Miller G, Mendelson WB. Sleep apnea syndrome in chronic renal disease.
Am J Med 1989;86(3):308-14.
21. Wadhwa NK, Mendelson WB. A comparison of sleep-disordered respiration in ESRD patients receiving hemodialysis and peritoneal dialysis. Adv Perit Dial 1992;8:195-8.
22. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328(17):1230-5.
23. Walker S, Fine A, Kryger MH. Sleep complaints are common in a dialysis unit. Am J Kidney Dis 1995;26(5):751-6.
24. Idler EL, Benyamini Y. Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 1997;38(1):21-37.
25. Rumsfeld JS, MaWhinney S, McCarthy M, Jr., et al. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes,
Structures, and Outcomes of Care in Cardiac Surgery. Jama 1999;281(14):1298-303.
26. Kimmel PL, Peterson RA, Weihs KL, et al. Psychosocial factors, behavioral
compliance and survival in urban hemodialysis patients. Kidney Int 1998;54(1):245-54.
27. Manu MA, Radulescu S, Harza M, Manu R, Capsa D, Sinescu I. Quality of life assessed by SF-36 health survey in renal transplant patients. Transplant Proc 2001;33(1-2):1927-8.
28. Mapes D, McCullough KP, Meredith D et al. Quality of life predicts mortality and hospitalization for hemodialysis patients in the US and Europe. J Am Soc Nephrol 1999(10):249A.
29. Phillips AL, Walker EL, Martin JE, First MR, Hanto DW, Whiting JF. Quality of life as a predictor of morbidity, mortality, and resource utilization after solid-organ
transplant. Transplant Proc 2001;33(1-2):1886.
30. Ross SD, Fahrbach K, Frame D, Scheye R, Connelly JE, Glaspy J. The effect of anemia treatment on selected health-related quality-of-life domains: a systematic review.
Clin Ther 2003;25(6):1786-805.
31. Xue JL, St Peter WL, Ebben JP, Everson SE, Collins AJ. Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kidney Dis
2002;40(6):1153-61.
32. Drueke TB, Eckardt KU, Frei U, et al. Does early anemia correction prevent complications of chronic renal failure? Clin Nephrol 1999;51(1):1-11.
33. Lim VS, DeGowin RL, Zavala D, et al. Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial. Ann Intern Med 1989;110(2):108-14.
34. Revicki DA, Brown RE, Feeny DH, et al. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 1995;25(4):548-54.
35. Fink J, Blahut S, Reddy M, Light P. Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis 2001;37(2):348-55.
36. Vanrenterghem Y, Ponticelli C, Morales JM, et al. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 2003;3(7):835-45.
37. Mix TC, Kazmi W, Khan S, et al. Anemia: a continuing problem following kidney transplantation. Am J Transplant 2003;3(11):1426-33.
38. Muirhead N, Cattran DC, Zaltzman J, et al. Safety and efficacy of recombinant human erythropoietin in correcting the anemia of patients with chronic renal allograft dysfunction. J Am Soc Nephrol 1994;5(5):1216-22.
39. McDowell I, Newell C. Measuring Health. New York: Oxford University Press, 1987:
205.
40. Apolone G, Mosconi P. Review of the concept of quality of life assessment and discussion of the present trend in clinical research. Nephrol Dial Transplant 1998;13 Suppl 1:65-9.
41. DeOreo PB. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis 1997;30(2):204-12.
42. Harris LE, Luft FC, Rudy DW, Tierney WM. Clinical correlates of functional status in patients with chronic renal insufficiency. Am J Kidney Dis 1993;21(2):161-6.
43. Rocco MV, Gassman JJ, Wang SR, Kaplan RM. Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. Am J Kidney Dis 1997;29(6):888-96.
44. Mingardi G, Cornalba L, Cortinovis E, Ruggiata R, Mosconi P, Apolone G. Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey. DIA-QOL Group. Nephrol Dial Transplant 1999;14(6):1503-10.
45. Moreno F, Lopez Gomez JM, Sanz-Guajardo D, Jofre R, Valderrabano F. Quality of life in dialysis patients. A spanish multicentre study. Spanish Cooperative Renal Patients Quality of Life Study Group. Nephrol Dial Transplant 1996;11 Suppl 2:125-9.
46. Simmons RG, Abress L. Quality-of-life issues for end-stage renal disease patients. Am J Kidney Dis 1990;15(3):201-8.
47. Jofre R, Lopez-Gomez JM, Moreno F, Sanz-Guajardo D, Valderrabano F. Changes in quality of life after renal transplantation. Am J Kidney Dis 1998;32(1):93-100.
48. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 1994;3(5):329-38.
49. Kimmel PL, Peterson RA, Weihs KL, et al. Aspects of quality of life in hemodialysis patients. J Am Soc Nephrol 1995;6(5):1418-26.
50. Kimmel PL, Peterson RA, Weihs KL, et al. Behavioral compliance with dialysis prescription in hemodialysis patients. J Am Soc Nephrol 1995;5(10):1826-34.
51. Welch JL, Austin JK. Quality of life in black hemodialysis patients. Adv Ren Replace Ther 1999;6(4):351-7.
52. Devins GM, Beanlands H, Mandin H, Paul LC. Psychosocial impact of illness
intrusiveness moderated by self-concept and age in end-stage renal disease. Health Psychol 1997;16(6):529-38.
53. McClellan WM, Anson C, Birkeli K, Tuttle E. Functional status and quality of life:
predictors of early mortality among patients entering treatment for end stage renal disease. J Clin Epidemiol 1991;44(1):83-9.
54. Sklar AH, Riesenberg LA, Silber AK, Ahmed W, Ali A. Postdialysis fatigue. Am J Kidney Dis 1996;28(5):732-6.
55. Kimmel PL, Peterson RA, Weihs KL, et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 2000;57(5):2093-8.
56. Daneker B, Kimmel PL, Ranich T, Peterson RA. Depression and marital dissatisfaction in patients with end-stage renal disease and in their spouses. Am J Kidney Dis 2001;38(4):839-46.
57. Kimmel PL. Psychosocial factors in adult end-stage renal disease patients treated with hemodialysis: correlates and outcomes. Am J Kidney Dis 2000;35(4 Suppl 1):S132-40.
58. Sacks CR, Peterson RA, Kimmel PL. Perception of illness and depression in chronic renal disease. Am J Kidney Dis 1990;15(1):31-9.
59. Lopes AA, Bragg J, Young E, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe.
Kidney Int 2002;62(1):199-207.
60. Christensen AJ, Wiebe JS, Smith TW, Turner CW. Predictors of survival among hemodialysis patients: effect of perceived family support. Health Psychol 1994;13(6):521-5.
61. Christensen AJ, Smith TW, Turner CW, Holman JM, Jr., Gregory MC, Rich MA.
Family support, physical impairment, and adherence in hemodialysis: an investigation of main and buffering effects. J Behav Med 1992;15(4):313-25.
62. House JS, Landis KR, Umberson D. Social relationships and health. Science 1988;241(4865):540-5.
63. McClellan WM, Stanwyck DJ, Anson CA. Social support and subsequent mortality among patients with end-stage renal disease. J Am Soc Nephrol 1993;4(4):1028-34.
64. Dwyer JT, Larive B, Leung J, et al. Nutritional status affects quality of life in
Hemodialysis (HEMO) Study patients at baseline. J Ren Nutr 2002;12(4):213-23.
65. Ohri-Vachaspati P, Sehgal AR. Quality of life implications of inadequate protein nutrition among hemodialysis patients. J Ren Nutr 1999;9(1):9-13.
66. Moreno F, Sanz-Guajardo D, Lopez-Gomez JM, Jofre R, Valderrabano F. Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. J Am Soc Nephrol 2000;11(2):335-42.
67. Evans RW, Manninen DL, Garrison LP, Jr., et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985;312(9):553-9.
68. Cameron JI, Whiteside C, Katz J, Devins GM. Differences in quality of life across renal replacement therapies: a meta-analytic comparison. Am J Kidney Dis
2000;35(4):629-37.
69. Fujisawa M, Ichikawa Y, Yoshiya K, et al. Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 health survey.
Urology 2000;56(2):201-6.
70. Rebollo P, Ortega F, Baltar JM, et al. Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it. Clin Transplant 2000;14(3):199-207.
71. Rebollo P, Ortega F, Baltar JM, Alvarez-Ude F, Alvarez Navascues R, Alvarez-Grande J. Is the loss of health-related quality of life during renal replacement therapy lower in elderly patients than in younger patients? Nephrol Dial Transplant
2001;16(8):1675-80.
72. Cameron JS. Renal transplantation in the elderly. Int Urol Nephrol 2000;32(2):193-201.
73. Jassal SV, Krahn MD, Naglie G, et al. Kidney transplantation in the elderly: a decision analysis. J Am Soc Nephrol 2003;14(1):187-96.
74. Johnson CD, Wicks MN, Milstead J, Hartwig M, Hathaway DK. Racial and gender differences in quality of life following kidney transplantation. Image J Nurs Sch 1998;30(2):125-30.
75. Baines LS, Joseph JT, Jindal RM. Emotional issues after kidney transplantation: a prospective psychotherapeutic study. Clin Transplant 2002;16(6):455-60.
76. Adang EM, Engel GL, van Hooff JP, Kootstra G. Comparison before and after transplantation of pancreas-kidney and pancreas-kidney with loss of pancreas--a prospective controlled quality of life study. Transplantation 1996;62(6):754-8.
77. Piehlmeier W, Bullinger M, Kirchberger I, Land W, Landgraf R. Evaluation of the quality of life of patients with insulin-dependent diabetes mellitus before and after organ transplantation with the SF 36 health survey. Eur J Surg 1996;162(12):933-40.
78. Esmatjes E, Ricart MJ, Fernandez-Cruz L, Gonzalez-Clemente JM, Saenz A, Astudillo E. Quality of life after successful pancreas-kidney transplantation. Clin Transplant 1994;8(2 Pt 1):75-8.
79. Sureshkumar KK, Mubin T, Mikhael N, Kashif MA, Nghiem DD, Marcus RJ.
Assessment of quality of life after simultaneous pancreas-kidney transplantation.
Am J Kidney Dis 2002;39(6):1300-6.
80. Simmons RG, Abress LK. Quality of life on cyclosporine versus conventional therapy.
Transplant Proc 1987;19(1 Pt 3):1860-1.
81. Hilbrands LB, Hoitsma AJ, Koene RA. The effect of immunosuppressive drugs on quality of life after renal transplantation. Transplantation 1995;59(9):1263-70.
82. Reimer J, Franke GH, Philipp T, Heemann U. Quality of life in kidney recipients:
comparison of tacrolimus and cyclosporine-microemulsion. Clin Transplant 2002;16(1):48-54.
83. Novák M. Az alvás - és ébrenléti zavarok diagnosztikája és terápiája. Budapest: Okker Kiadó, 2000.
84. Riemann D, Berger M, Voderholzer U. Sleep and depression--results from psychobiological studies: an overview. Biol Psychol 2001;57(1-3):67-103.
85. Vizi J, Novák M. Alvászavarok és pszichiátriai betegségek. In: M N, ed. Az alvás - és ébrenléti zavarok diagnosztikája és terápiája. Budapest: Okker Kiadó, 2000: 227-242.
86. Gillin JC. Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatr Scand Suppl 1998;393:39-43.
87. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4(2):101-19.
88. De Backer WA. Central sleep apnoea, pathogenesis and treatment: an overview and perspective. Eur Respir J 1995;8(8):1372-83.
89. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165(9):1217-39.
90. Boland LL, Shahar E, Iber C, Knopman DS, Kuo TF, Nieto FJ. Measures of cognitive function in persons with varying degrees of sleep-disordered breathing: the Sleep Heart Health Study. J Sleep Res 2002;11(3):265-72.
91. Baldwin CM, Griffith KA, Nieto FJ, O'Connor GT, Walsleben JA, Redline S. The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep 2001;24(1):96-105.
92. Gottlieb DJ, Whitney CW, Bonekat WH, et al. Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med 1999;159(2):502-7.
93. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. Jama 2000;283(14):1829-36.
94. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002;162(8):893-900.
95. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342(19):1378-84.
96. Ball EM, Simon RD, Jr., Tall AA, Banks MB, Nino-Murcia G, Dement WC. Diagnosis and treatment of sleep apnea within the community. The Walla Walla Project. Arch Intern Med 1997;157(4):419-24.
97. Novak M, Molnar M, Rethelyi J, Csepanyi G, Vamos E, Csehi SZ, Mucsi I. Reported Sleep Problems and Illness Intrusiveness in Patients on maintenance Hemodialysis.
J Am Soc Nephrol 2000;10(9):A160.
98. Novak M, Molnar M, Rethelyi J, Vamos E, Csepanyi G., Csehi Sz, Mucsi I. Subjective sleep complaints in patients on renal replacement therapy. Sleep 2001;24:A 377.
99. Han SY, Yoon JW, Jo SK, et al. Insomnia in diabetic hemodialysis patients. Prevalence and risk factors by a multicenter study. Nephron 2002;92(1):127-32.
100. Hui DS, Wong TY, Ko FW, et al. Prevalence of sleep disturbances in chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000;36(4):783-8.
101. Hui DS, Wong TY, Li TS, et al. Prevalence of sleep disturbances in Chinese patients with end stage renal failure on maintenance hemodialysis. Med Sci Monit
2002;8(5):CR331-6.
102. Venmans BJ, van Kralingen KW, Chandi DD, de Vries PM, ter Wee PM, Postmus PE.
Sleep complaints and sleep disordered breathing in hemodialysis patients. Neth J Med 1999;54(5):207-12.
103. Wetter TC. Restless legs syndrome: a review for the renal care professionals. Edtna Erca J 2001;27(1):42-6.
104. Holley JL, Nespor S, Rault R. Characterizing sleep disorders in chronic hemodialysis patients. ASAIO Trans 1991;37(3):M456-7.
105. Burmann-Urbanek M, Sanner B, Laschewski F, et al. [Sleep disorders in patients with dialysis-dependent renal failure]. Pneumologie 1995;49 Suppl 1:158-60.
106. Kutner NG, Bliwise DL, Brogan D, Zhang R. Race and restless sleep complaint in older chronic dialysis patients and nondialysis community controls. J Gerontol B Psychol Sci Soc Sci 2001;56(3):P170-5.
107. Puntriano M. The relationship between dialysis adequacies and sleep problems in hemodialysis patients. Anna J 1999;26(4):405-7.
108. De Vecchi A, Finazzi S, Padalino R, et al. Sleep disorders in peritoneal and
haemodialysis patients as assessed by a self-administered questionnaire. Int J Artif Organs 2000;23(4):237-42.
109. Williams SW, Tell GS, Zheng B, Shumaker S, Rocco MV, Sevick MA. Correlates of sleep behavior among hemodialysis patients. The kidney outcomes prediction and evaluation (KOPE) study. Am J Nephrol 2002;22(1):18-28.
110. Lui SL, Ng F, Lo WK. Factors associated with sleep disorders in Chinese patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2002;22(6):677-82.
111. Bliwise DL, Kutner NG, Zhang R, Parker KP. Survival by time of day of hemodialysis in an elderly cohort. Jama 2001;286(21):2690-4.
112. Mendelson WB, Wadhwa NK, Greenberg HE, Gujavarty K, Bergofsky E. Effects of hemodialysis on sleep apnea syndrome in end-stage renal disease. Clin Nephrol 1990;33(5):247-51.
113. Veiga J, Goncalves N, Gomes F et al. Sleep disturbances in end-stage renal disease patients on hemodialysis. Dial Transplant 1997;26(6):380-384.
114. De Santo RM, Lucidi F, Violani C, Bertini M. Insomnia is associated with systolic hypertension in uremic patients on hemodialysis. Int J Artif Organs
2001;24(12):853-62.
115. Vaziri ND, Oveisi F, Reyes GA, Zhou XJ. Dysregulation of melatonin metabolism in chronic renal insufficiency: role of erythropoietin-deficiency anemia. Kidney Int 1996;50(2):653-6.
116. Ludemann P, Zwernemann S, Lerchl A. Clearance of melatonin and
6-sulfatoxymelatonin by hemodialysis in patients with end-stage renal disease. J Pineal Res 2001;31(3):222-7.
117. Craven JL, Rodin GM, Johnson L, Kennedy SH. The diagnosis of major depression in renal dialysis patients. Psychosom Med 1987;49(5):482-92.
118. Kimmel PL. Depression in patients with chronic renal disease: what we know and what we need to know. J Psychosom Res 2002;53(4):951-6.
119. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160(14):2137-41.
120. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 1996;28(3):372-8.
121. Roger SD, Harris DC, Stewart JH. Possible relation between restless legs and anaemia in renal dialysis patients. Lancet 1991;337(8756):1551.
122. Hallett M, Burden S, Stewart D, Mahony J, Farrell P. Sleep apnea in end-stage renal disease patients on hemodialysis and continuous ambulatory peritoneal dialysis.
Asaio J 1995;41(3):M435-41.
123. Zoccali C. Sleep apnoea and nocturnal hypoxaemia in dialysis patients: mere risk-indicators or causal factors for cardiovascular disease? Nephrol Dial Transplant 2000;15(12):1919-21.
124. Zoccali C, Benedetto FA, Mallamaci F, et al. Left ventricular hypertrophy and nocturnal hypoxemia in hemodialysis patients. J Hypertens 2001;19(2):287-93.
125. Zoccali C, Mallamaci F, Tripepi G. Sleep apnea in renal patients. J Am Soc Nephrol 2001;12(12):2854-9.
126. Silverberg DS, Iaina A, Ocksenberg A. Sleep-related breathing disturbances: their pathogenesis and potential interest to the nephrologist. Nephrol Dial Transplant 1997;12(4):680-3.
127. Zoccali C, Mallamaci F, Tripepi G. Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients. J Am Soc Nephrol 2002;13(3):729-33.
128. Neu AM, Furth SL, Case BW, Wise B, Colombani PM, Fivush BA. Evaluation of neurotoxicity in pediatric renal transplant recipients treated with tacrolimus (FK506). Clin Transplant 1997;11(5 Pt 1):412-4.
129. Kemper MJ, Sparta G, Laube GF, Miozzari M, Neuhaus TJ. Neuropsychologic side-effects of tacrolimus in pediatric renal transplantation. Clin Transplant
2003;17(2):130-4.
130. Langevin B, Fouque D, Leger P, Robert D. Sleep apnea syndrome and end-stage renal disease. Cure after renal transplantation. Chest 1993;103(5):1330-5.
131. Auckley DH, Schmidt-Nowara W, Brown LK. Reversal of sleep apnea hypopnea syndrome in end-stage renal disease after kidney transplantation. Am J Kidney Dis 1999;34(4):739-44.
132. Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord 2002;17(5):1072-6.
133. Chang WK, Hung KY, Huang JW, Wu KD, Tsai TJ. Chronic fatigue in long-term peritoneal dialysis patients. Am J Nephrol 2001;21(6):479-85.
134. Molnar M, Novak M, Ambrus CS, Zambo M, Vamos E, Kovacs A, Csepanyi G, Dobos M, Mucsi I. Subjective sleep complaints and quality of life in patients on maintenance haemodialysis using the Kidney Disease Quality of Life Questionnaire.
J Sleep Res 2002;11(Suppl. 1):156.
135. Chevalier H, Los F, Boichut D, et al. Evaluation of severe insomnia in the general population: results of a European multinational survey. J Psychopharmacol 1999;13(4 Suppl 1):S21-4.
136. McCrae C, Lichstein KL. Secondary insomnia: diagnostic challenges and intervention opportunities. Sleep Med Rev 2001;5(1):47-61.
137. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep 1999;22 Suppl 2:S379-85.
138. Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep 1999;22 Suppl 2:S386-93.
139. Kapur VK, Redline S, Nieto FJ, Young TB, Newman AB, Henderson JA. The relationship between chronically disrupted sleep and healthcare use. Sleep 2002;25(3):289-96.
140. Leger D, Guilleminault C, Bader G, Levy E, Paillard M. Medical and socio-professional impact of insomnia. Sleep 2002;25(6):625-9.
141. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997;154(10):1417-23.
142. Chilcott LA, Shapiro CM. The socioeconomic impact of insomnia. An overview.
Pharmacoeconomics 1996;10 Suppl 1:1-14.
143. Allen R, Earley CJ. Validation of a diagnostic questionnaire for the restless legs syndrome (RLS). Neurology 2001;56 (Suppl 3):4A.
144. Kasiske BL, Vazquez MA, Harmon WE, et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000;11 Suppl 15:S1-86.
145. Lorenz M, Kletzmayr J, Perschl A, Furrer A, Horl WH, Sunder-Plassmann G. Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol 2002;13(3):794-7.
146. Miles AM, Markell MS, Daskalakis P, et al. Anemia following renal transplantation:
erythropoietin response and iron deficiency. Clin Transplant 1997;11(4):313-5.
147. Loge J, Lange RD, Moore CV. Characterization of the anemia associated with chronic renal insufficiency. Am J Med 1958;24:4-18.